Skip to main content

and
  1. Article

    Open Access

    AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas

    AXL is a well-characterized, protumorigenic receptor tyrosine kinase that is highly expressed and activated in numerous human carcinomas and sarcomas, including aggressive subtypes of liposarcoma. However, the...

    Caitlin D. May, Jeannine Garnett, **aoYan Ma, Sharon M. Landers in BMC Cancer (2015)